• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中的微生物特征:探索全身生态位的新潜力

Microbial Signatures in Breast Cancer: Exploring New Potentials Across Body Niches.

作者信息

Wong Alicia Yoke Wei, Bicchieraro Giulia, Palumbo Isabella, Ciabattoni Antonella, Aristei Cynthia, Spaccapelo Roberta

机构信息

Department of Medicine and Surgery and Center of Functional Genomics (C.U.R.Ge.F), University of Perugia, 06132 Perugia, Italy.

Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

出版信息

Int J Mol Sci. 2025 Sep 5;26(17):8654. doi: 10.3390/ijms26178654.

DOI:10.3390/ijms26178654
PMID:40943572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12429330/
Abstract

Breast cancer is one of the most frequently diagnosed malignancies and remains the leading cause of cancer-related death among women worldwide. Emerging evidence implicates the microbiota to be a potential contributor to its pathogenesis and progression. This review summarizes emerging evidence of microbial alterations across various body niches in breast cancer patients, including gut, breast tissue, nipple aspirate fluid (NAF), oral cavity, skin, urinary and reproductive tracts, and blood. Reductions in commensal taxa such as , , , , and , along with an increase in pro-inflammatory genera like , , and , may promote breast tumor development and progression through multiple pathways including modulation of estrogen metabolism, production of microbial metabolites, and immunoregulation. The presence of cross-niche overlaps and possible translocation of microbiota between niches through the bloodstream suggests the existence of a complex interconnected oral-gut-breast microbiota axis. Progress in the field will depend on integrative multi-omics, translational approaches, and longitudinal studies to give a clearer mechanistic understanding of microbiota-host interactions to develop feasible microbiota-based biomarkers and therapeutic strategies in breast cancer.

摘要

乳腺癌是最常被诊断出的恶性肿瘤之一,并且仍然是全球女性癌症相关死亡的主要原因。新出现的证据表明,微生物群可能是其发病机制和进展的一个潜在因素。本综述总结了乳腺癌患者各个身体部位微生物改变的新证据,包括肠道、乳腺组织、乳头抽吸液(NAF)、口腔、皮肤、泌尿生殖道和血液。共生菌属如、、、和的减少,以及促炎菌属如、和的增加,可能通过多种途径促进乳腺肿瘤的发展和进展,包括调节雌激素代谢、产生微生物代谢产物和免疫调节。不同身体部位之间存在交叉重叠以及微生物群可能通过血液在不同部位之间转移,这表明存在一个复杂的相互关联的口腔-肠道-乳腺微生物群轴。该领域的进展将取决于整合多组学、转化方法和纵向研究,以便更清楚地了解微生物群与宿主的相互作用机制,从而开发出可行的基于微生物群的乳腺癌生物标志物和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba2/12429330/c9a7a083252c/ijms-26-08654-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba2/12429330/c9a7a083252c/ijms-26-08654-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba2/12429330/c9a7a083252c/ijms-26-08654-g001.jpg

相似文献

1
Microbial Signatures in Breast Cancer: Exploring New Potentials Across Body Niches.乳腺癌中的微生物特征:探索全身生态位的新潜力
Int J Mol Sci. 2025 Sep 5;26(17):8654. doi: 10.3390/ijms26178654.
2
Integrated oral-gut microbiota therapy: a novel perspective on preventing bacterial translocation for systemic disease management.口腔-肠道微生物群综合疗法:预防细菌易位以管理全身性疾病的新视角。
Front Cell Infect Microbiol. 2025 Jul 28;15:1641816. doi: 10.3389/fcimb.2025.1641816. eCollection 2025.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
The Oral-Gut Microbiota Axis Across the Lifespan: New Insights on a Forgotten Interaction.贯穿一生的口腔-肠道微生物群轴:对一种被遗忘的相互作用的新见解。
Nutrients. 2025 Aug 1;17(15):2538. doi: 10.3390/nu17152538.
5
Integrated multi-omics analysis reveals the functional signature of microbes and metabolomics in pre-diabetes individuals.综合多组学分析揭示了糖尿病前期个体中微生物和代谢组学的功能特征。
Microbiol Spectr. 2025 Jul;13(7):e0145924. doi: 10.1128/spectrum.01459-24. Epub 2025 Jun 9.
6
The association between gut microbiota composition and cardiometabolic parameters in healthy adults.健康成年人肠道微生物群组成与心脏代谢参数之间的关联。
BMC Microbiol. 2025 Aug 14;25(1):505. doi: 10.1186/s12866-025-04261-4.
7
Gut, vaginal, and urinary microbiota as potential biomarkers of sensitization in women with chronic pelvic pain.肠道、阴道和泌尿微生物群作为慢性盆腔疼痛女性致敏反应的潜在生物标志物。
Am J Obstet Gynecol. 2025 Jan 16. doi: 10.1016/j.ajog.2025.01.013.
8
Radiation-induced injury and the gut microbiota: insights from a microbial perspective.辐射诱导损伤与肠道微生物群:从微生物视角的见解
Therap Adv Gastroenterol. 2025 Jun 16;18:17562848251347347. doi: 10.1177/17562848251347347. eCollection 2025.
9
Gut Microbiota-Derived Metabolites Orchestrate Metabolic Reprogramming in Diabetic Cardiomyopathy: Mechanisms and Therapeutic Frontiers.肠道微生物群衍生代谢物调控糖尿病心肌病中的代谢重编程:机制与治疗前沿
FASEB J. 2025 Sep 15;39(17):e71004. doi: 10.1096/fj.202501579RR.
10
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.

本文引用的文献

1
Oral Combined Probiotics Clostridium butyricum and Akkermansia muciniphila Inhibits the Progression of 4T1 Breast Cancer by Activating Bcl-2/Bax Pathway.口服丁酸梭菌和嗜黏蛋白阿克曼氏菌联合益生菌通过激活Bcl-2/Bax通路抑制4T1乳腺癌进展。
Cancer Med. 2025 Jun;14(11):e70987. doi: 10.1002/cam4.70987.
2
Relevance of oncobiome in breast cancer evolution in an Argentine cohort.阿根廷队列中肿瘤微生物群在乳腺癌进展中的相关性
mSphere. 2025 Mar 25;10(3):e0059724. doi: 10.1128/msphere.00597-24. Epub 2025 Feb 10.
3
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide.
《2022年全球癌症统计报告》:数据来源、方法及全球癌症负担概述
Int J Cancer. 2025 Apr 1;156(7):1336-1346. doi: 10.1002/ijc.35278. Epub 2024 Dec 17.
4
Integrated analysis of microbiota and gut microbial metabolites in blood for breast cancer.血液中微生物群和肠道微生物代谢物的综合分析在乳腺癌中的应用。
mSystems. 2024 Nov 19;9(11):e0064324. doi: 10.1128/msystems.00643-24. Epub 2024 Oct 18.
5
A Clustering Study of Sociodemographic Data, Dietary Patterns, and Gut Microbiota in Healthy and Breast Cancer Women Participating in the MICROMA Study.《MICROMA 研究中健康女性和乳腺癌女性的社会人口统计学数据、饮食模式和肠道微生物群的聚类研究》
Mol Nutr Food Res. 2024 Aug;68(15):e2400253. doi: 10.1002/mnfr.202400253. Epub 2024 Jul 1.
6
Current progresses and challenges for microbiome research in human health: a perspective.人类健康微生物组研究的当前进展和挑战:一个视角。
Front Cell Infect Microbiol. 2024 Apr 4;14:1377012. doi: 10.3389/fcimb.2024.1377012. eCollection 2024.
7
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms.接受芳香化酶抑制剂治疗的乳腺癌幸存者的阴道微生物组,伴有或不伴有外阴阴道症状。
Sci Rep. 2024 Mar 28;14(1):7417. doi: 10.1038/s41598-024-58118-3.
8
Breast cancer but not the menopausal status is associated with small changes of the gut microbiota.乳腺癌而非绝经状态与肠道微生物群的微小变化有关。
Front Oncol. 2024 Jan 24;14:1279132. doi: 10.3389/fonc.2024.1279132. eCollection 2024.
9
Association of Skin Microbiome Dynamics With Radiodermatitis in Patients With Breast Cancer.皮肤微生物组动态与乳腺癌患者放射性皮炎的关联。
JAMA Oncol. 2024 Apr 1;10(4):516-521. doi: 10.1001/jamaoncol.2023.6533.
10
Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis.基于 16S rRNA 基因测序的乳腺癌患者粪便微生物组变化:系统评价和荟萃分析。
Clin Transl Oncol. 2024 Jun;26(6):1480-1496. doi: 10.1007/s12094-023-03373-5. Epub 2024 Jan 13.